Clinical validation of five direct-to-consumer smartwatches to detect atrial fibrillation in a Real-World Cohort of Patients: BASEL Wearable Study

被引：0
|
作者：
Mannhart, D. [1 ]
Hennings, E. [1 ]
Lischer, M. [1 ]
Vogeli, D. [1 ]
de lavallaz, J. Du Fay [1 ]
Knecht, S. [1 ]
Schaer, B. [1 ]
Osswald, S. [1 ]
Kuhne, M. [1 ]
Sticherling, C. [1 ]
Badertscher, P. [1 ]
机构：
[1] Univ Hosp Basel, Dept Cardiol, Basel, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2022年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O43
引用
收藏
页码：30S / 30S
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF NOACS IN PATIENTS WITH ATRIAL FIBRILLATION: USING REAL-WORLD DATA FOR EXTERNAL VALIDATION
    de Jong, L.
    Groeneveld, J.
    Stevanovic, J.
    Rila, H.
    Tieleman, R. G.
    Huisman, M.
    Postma, M.
    van Hulst, M.
    VALUE IN HEALTH, 2019, 22 : S546 - S546
  • [32] Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study
    Russo, Vincenzo
    Attena, Emilio
    Di Maio, Marco
    Mazzone, Carmine
    Carbone, Andreina
    Parisi, Valentina
    Rago, Anna
    D'Onofrio, Antonio
    Golino, Paolo
    Nigro, Gerardo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (01) : 42 - 53
  • [33] Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study
    Vincenzo Russo
    Emilio Attena
    Marco Di Maio
    Carmine Mazzone
    Andreina Carbone
    Valentina Parisi
    Anna Rago
    Antonio D’Onofrio
    Paolo Golino
    Gerardo Nigro
    Journal of Thrombosis and Thrombolysis, 2020, 49 : 42 - 53
  • [34] Suboptimal Management of Patients with Non-valvular Atrial Fibrillation: Real-world Clinical Setting
    Lau, Wallis C. Y.
    Chan, Esther W.
    Wong, Ian C. K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 380 - 380
  • [35] Do clinical trial cohorts reflect the complexities of real-world patients with chronic atrial fibrillation?
    Ball, J.
    Carrington, M. J.
    Stewart, S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 955 - 955
  • [36] Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation in the Real-world: The Fushimi AF Registry
    Yamashita, Yugo
    Uozumi, Ryuji
    Esato, Masahiro
    Chun, Yeong-Hwa
    Wada, Hiromichi
    Hasegawa, Koji
    Ogawa, Hisashi
    Abe, Mitsuru
    Morita, Satoshi
    Akao, Masaharu
    CIRCULATION, 2016, 134
  • [37] Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation in the Real-world: The Fushimi AF Registry
    Yamashita, Yugo
    Uozumi, Ryuji
    Esato, Masahiro
    Chun, Yeong-Hwa
    Wada, Hiromichi
    Hasegawa, Koji
    Ogawa, Hisashi
    Abe, Mitsuru
    Morita, Satoshi
    Akao, Masaharu
    CIRCULATION, 2016, 134
  • [38] Real-world evidence of direct oral anticoagulants in patients with atrial fibrillation and cancer: A meta-analysis
    Li, Xiuying
    Li, Runkai
    Zhu, Wengen
    Wu, Dexi
    IJC HEART & VASCULATURE, 2024, 55
  • [39] Atrial fibrillation detection using insertable cardiac monitor after stroke: A real-world cohort study
    Noubiap, Jean J.
    Thomas, Gijo
    Middeldorp, Melissa E.
    Fitzgerald, John L.
    Harper, Curtis
    Sanders, Prashanthan
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2023, 34 (01) : 142 - 146
  • [40] Comparison of clinical outcomes with edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonist in patients with atrial fibrillation in Germany: a real-world cohort study
    Marston, X. L.
    Wang, R.
    Yeh, Y. C.
    Zimmermann, L.
    Ye, X.
    Gao, X.
    Unverdorben, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 401 - 401
12345